Health care workers’ experiences with implementation of “screen and treat” for cervical cancer prevention in Malawi: A qualitative study

被引:2
作者
Moucheraud C. [1 ]
Kawale P. [2 ]
Kafwafwa S. [3 ]
Bastani R. [1 ]
Hoffman R.M. [4 ]
机构
[1] University of California Fielding School of Public Health, Los Angeles, CA
[2] African Institute for Development Policy, Lilongwe
[3] Partners in Hope Medical Center, Lilongwe
[4] University of California Geffen School of Medicine, Los Angeles, CA
来源
Implementation Science Communications | / 1卷 / 1期
基金
美国国家卫生研究院;
关键词
Cervical cancer; CFIR; Global health; Screening;
D O I
10.1186/s43058-020-00097-3
中图分类号
学科分类号
摘要
Background: Cervical cancer remains a major cause of mortality and morbidity in low- and middle-income countries, despite the availability of effective prevention approaches. “Screen and treat” (a single-visit strategy to identify and remove abnormal cervical cells) is the recommended secondary prevention approach in low-resource settings, but there has been relatively scarce robust implementation science evidence on barriers and facilitators to providing “screen and treat” from the provider perspective, or about thermocoagulation as a lesion removal technique. Methods: Informed by the Consolidated Framework for Implementation Research (CFIR), we conducted interviews with ten experienced “screen and treat” providers in Malawi. We asked questions based on the CFIR Guide, used the CFIR Guide codebook for a descriptive analysis in NVivo, and added recommended modifications for studies in low-income settings. Results: Seven CFIR constructs were identified as positively influencing implementation, and six as negatively influencing implementation. The two strong positive influences were the relative advantage of thermocoagulation versus cryotherapy (Innovation Characteristics) and respondents’ knowledge and beliefs about providing “screen and treat” (Individual Characteristics). The two strong negative influences were the availability of ongoing refresher trainings to stay up-to-date on skills (Inner Setting, Implementation Climate) and insufficient resources (staffing, infrastructure, supplies) to provide “screen and treat” to all women who need it (Inner Setting, Readiness for Implementation). Weak positive factors included perceived scalability and access to knowledge/information, as well as compatibility, leadership engagement, and team characteristics, but these latter three were mixed in valence. Weak negative influences were structural characteristics and donor priorities; and mixed but weakly negative influences were relative priority and engaging clients. Cross-cutting themes included the importance of broad buy-in (including different cadres of health workers and leadership at the facility and in the government) and the opportunities and challenges of offering integrated care (screening plus other services). Conclusions: Although “screen and treat” is viewed as effective and important, many implementation barriers remain. Our findings suggest that implementation strategies will need to be multi-level, include a diverse set of stakeholders, and explicitly address both screening and treatment. © 2020, The Author(s).
引用
收藏
相关论文
共 62 条
  • [11] Dolman L., Sauvaget C., Muwonge R., Sankaranarayanan R., Meta-analysis of the efficacy of cold coagulation as a treatment method for cervical intraepithelial neoplasia: a systematic review, BJOG, 121, 8, pp. 929-942, (2014)
  • [12] McCarthy C., Ramphul M., Madden M., Hickey K., The use and success of cold coagulation for the treatment of high grade squamous cervical intra-epithelial neoplasia: a retrospective review, Eur J Obstet Gynecol Reprod Biol, 203, pp. 225-228, (2016)
  • [13] Nessa A., Naud P., Esmy P.O., Joshi S., Rema P., Wesley R., Kamal M., Sauvaget C., Muwonge R., Sankaranarayanan R., Efficacy, safety, and acceptability of thermal coagulation to treat cervical intraepithelial neoplasia: pooled data from Bangladesh, Brazil and India, J Clin Gynecol Obstet, 6, 3-4, pp. 58-64, (2017)
  • [14] Oga E.A., Brown J.P., Brown C., Dareng E., Adekanmbi V., Odutola M., Olaniyan O., Offiong R., Obende K., Adewole A.S., Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women, BMC Womens Health, 16, 1, (2016)
  • [15] Viviano M., Kenfack B., Catarino R., Tincho E., Temogne L., Benski A.-C., Tebeu P.-M., Meyer-Hamme U., Vassilakos P., Petignat P., Feasibility of thermocoagulation in a screen-and-treat approach for the treatment of cervical precancerous lesions in sub-Saharan Africa, BMC Womens Health, 17, 1, (2017)
  • [16] Randall T.C., Sauvaget C., Muwonge R., Trimble E.L., Jeronimo J., Worthy of further consideration: an updated meta-analysis to address the feasibility, acceptability, safety and efficacy of thermal ablation in the treatment of cervical cancer precursor lesions, Prev Med, 118, pp. 81-91, (2018)
  • [17] Pinder L.F., Parham G.P., Basu P., Muwonge R., Lucas E., Nyambe N., Sauvaget C., Mwanahamuntu M.H., Sankaranarayanan R., Prendiville W., Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: Pilot phase of a randomised controlled trial, Lancet Oncol, 21, 1, pp. 175-184, (2019)
  • [18] National cervical cancer control strategy 2016-2020, . Lilongwe: Government of Malawi, Ministry of Health and Population, (2017)
  • [19] National reproductive health service delivery guidelines, (2014)
  • [20] Gakidou E., Nordhagen S., Obermeyer Z., Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities, PLoS Med, 5, 6, (2008)